Annexin presents at Redeye Investor Forum in Gothenburg on September 14
Annexin Pharmaceuticals AB today announced that the company is participating at Redeye Investor Forum in Gothenburg on September 14, 2023, 18:00-20:00 CET. CEO Anders Haegerstrand will present the latest development of the company, including the recently presented promising signals of effect in the company’s ongoing clinical RVO-study. The presentation and moderated Q&A session is broadcasted live via Redeye’s website www.redeye.se/events/ , where registration for in-person attendance at Hotel Pigalle, Södra Hamngatan 2A in